ZXE-29913-90432
2 vaccinations
1 coded response
12 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 630 / MO
- Registered
- 2021-01-08
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-08
Registered in v-safe
-
2021-01-08
Dose 1 — Pfizer-BioNTech
- 2021-01-12
- 2021-01-15
- 2021-01-22
- 2021-01-29
- 2021-02-05
-
2021-02-09
Dose 2 — Pfizer-BioNTech
- 2021-02-19
- 2021-02-23
- 2021-03-02
- 2021-03-09
- 2021-03-16
-
2021-03-25
Survey response — day 42, dose 2MedDRA: Abortion spontaneous, Uterine dilation and curettage — Feeling: Poor · Get care from a doctor or other healthcare professional · HospitalizationFree text: Symptoms: Miscarriage · Healthcare visit (other): D cMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-25
Report sent to call center — day 42, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-04-09
- 2021-05-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-08 | Pfizer-BioNTech | |
| 2 | 2021-02-09 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-03-25 | Unsuccessful |
Free text
Release 6 — day 42, dose 2
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Uterine dilation and curettage | ✓ | ✓ | ✓ |
| SD | Abortion spontaneous | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release